Dsm-Firmenich Sells ANH Business to CVC Capital Partners for EUR2.2B; Shares Drop

Dsm-Firmenich (OTC: DSMF) agreed to sell its ANH business to CVC Capital Partners for EUR220 million, effective February 28, 2026. The transaction, subject to regulatory approvals, is expected to close in Q1 2026. DSMF shares fell 3.2% in early trading on February 9, 2026, reflecting the strategic shift. The ANH business, focused on animal nutrition and health, will operate under CVC's portfolio, which has expanded its presence in life sciences and agri-food sectors. Financial terms include a EUR220 million upfront payment, with additional earn-out contingent on post-acquisition performance. The sale reflects DSMF's focus on divesting non-core assets to strengthen its core portfolio.